MONROE, Mich. (AP) - Jessie Kelly wanted to honor the woman who gave her life. On Sept. 20, she hosted a celebration for Nariana Petty, a 26-year-old woman originally from Phoenix whose stem cells saved her. Family and friends gathered to thank Petty and her husband, Chris, for saving Kellys life. The celebration took place at Oakridge Estates Community Center. The Pettys were given baskets filled with items from Michigan, including wine, maple syrup and more.

But the day was about more than just food and fun. It was the first time the women met face to face.

In 2008, Kelly was diagnosed with non-Hodgkin lymphoma. When chemotherapy did not work, she was given a bone marrow transplant - using her own bone marrow - at Karmanos Cancer Institute in Detroit.

But after 90 days, she received demoralizing news.

It failed. The transplant didnt take, the 57-year-old Monroe resident said. It was emotionally devastating.

Kellys five siblings were tested, and no one was a match, the Monroe News (http://bit.ly/1sl9S8C ) reported.

I was devastated, she said. I thought for sure one of them would be a match, but that wasnt the case.

Her transplant nurse told her about the National Bone Marrow Registry. Within two weeks, Kelly received a call saying they had found a match.

Kelly and Petty didnt meet when the stem cells were harvested two years ago. For confidentiality reasons, they had to wait a year before they learned about each other.

When she got the call, Petty, 26, was living out West and flew to Detroit for the stem cell harvest. For a few days, she was given shots, and, on Sept. 14, 2012, the bone marrow was extracted from her neck.

See the original post here:
Michigan bone marrow recipient meets her donor

Recommendation and review posted by Bethany Smith

Pathology and Genetics of FTD
Dr James Burrell, of the NeuRA Frontier research group, talks about the pathology and genetics of frontotemporal dementia.

By: Neuroscience Research Australia

More:
Pathology and Genetics of FTD - Video

Recommendation and review posted by Bethany Smith

Morning Jew Ep. 52: Jewish Genetics, Dating intermarriage author illustrator Lisa Brown
Comics Heather Gold (@heathr) and Katie Halper (@kthalps) look at the headlines and ask: Is it good for the Jews? This week we talk more with genius Lisa Bro...

By: Morning Jew

Here is the original post:
Morning Jew Ep. 52: Jewish Genetics, Dating intermarriage & author illustrator Lisa Brown - Video

Recommendation and review posted by Bethany Smith

Oceangrown genetics @tlpc Deimos grow wrap up
Pleased to have oceangrown genetics at tender loving patient caregivers. Delayed wrap up video of autos, more endeavors to come! Thanks for watching.

By: Diavoloquasar .dq

Link:
Oceangrown genetics @tlpc Deimos grow wrap up - Video

Recommendation and review posted by Bethany Smith

Genetics - Cinema Show - Teatro Rival - RJ - 26/09/2014
Descrio.

By: Nelson Santos

View post:
Genetics - Cinema Show - Teatro Rival - RJ - 26/09/2014 - Video

Recommendation and review posted by Bethany Smith

Genetics - Supper #39;s Ready (part 1) - Teatro Rival - RJ - 26/09/2014
Descrio.

By: Nelson Santos

Original post:
Genetics - Supper's Ready (part 1) - Teatro Rival - RJ - 26/09/2014 - Video

Recommendation and review posted by Bethany Smith

GENETICS - I KNOW WHAT I LIKE - TEATRO RIVAL - video by Rogerio Favilla
TEATRO RIVAL - RIO DE JANEIRO - 26/09/2014 it #39;s one o #39;clock and time for lunch, When the sun beats down and I lie on the bench I can always hear them talk. There #39;s always been ethel: Jacob,...

By: Lakranya1

Excerpt from:
GENETICS - I KNOW WHAT I LIKE - TEATRO RIVAL - video by Rogerio Favilla - Video

Recommendation and review posted by Bethany Smith

Muscular Myopathy in Dog
X-Linked Myotubular Myopathy in Dogs and related Gene Therapy.

By: Amanda Tawde

Here is the original post:
Muscular Myopathy in Dog - Video

Recommendation and review posted by Bethany Smith

Personalized Medicine The Glucocorticoid Receptor, David Greenhalgh, M.D.
Department of Surgery Grand Rounds 080514 Speaker: David Greenhalgh, M.D. Burn Surgery.

By: UC Davis Department of Surgery

Visit link:
Personalized Medicine The Glucocorticoid Receptor, David Greenhalgh, M.D. - Video

Recommendation and review posted by sam

Science 2014: Pharmacogenomics Resource for Implementing Personalized Medicine
Description.

By: Pitt Innovation Institute

Continued here:
Science 2014: Pharmacogenomics Resource for Implementing Personalized Medicine - Video

Recommendation and review posted by sam

About the Turning the Tide Against Cancer Co-Conveners: Personalized Medicine Coalition
The Personalized Medicine Coalition (PMC) is an education and advocacy organization that is focused on encouraging innovation in personalized medicine. Learn more about their role as a co-convener...

By: TTTACancer

Follow this link:
About the Turning the Tide Against Cancer Co-Conveners: Personalized Medicine Coalition - Video

Recommendation and review posted by sam

Turning the Tide Against Cancer 2014 Conference: Looking Ahead
Find out what the Personalized Medicine Coalition (PMC) is hoping to achieve at the Turning the Tide Against Cancer 2014 Conference on October 9, 2014. Learn more about the conference at http://tur...

By: TTTACancer

Read the original:
Turning the Tide Against Cancer 2014 Conference: Looking Ahead - Video

Recommendation and review posted by sam

The Modified Spinal Cord Injury Functional Ambulation Profile (mSCI-FAP) #3 Obstacles Task
mSCI-FAP tasks are timed walking tests measuring the performance of 4 common walking tasks. This video covers walking and negotiating obstacles.

By: RickHansenInstitute

See more here:
The Modified Spinal Cord Injury Functional Ambulation Profile (mSCI-FAP) #3 Obstacles Task - Video

Recommendation and review posted by sam

The Modified Spinal Cord Injury Functional Ambulation Profile (mSCI-FAP) #1 Carpet Task
mSCI-FAP tasks are timed walking tests measuring the performance of 4 common walking tasks. This video covers walking on carpet.

By: RickHansenInstitute

See the original post here:
The Modified Spinal Cord Injury Functional Ambulation Profile (mSCI-FAP) #1 Carpet Task - Video

Recommendation and review posted by sam

Jose H. a C-5 Incomplete Spinal Cord Injury at BeyondThe Chair
This video is about Jose H a C-5 Incomplete Spinal Cord Injury and his recovery at Beyond The Chair.

By: Nito Blochlinger

Read the rest here:
Jose H. a C-5 Incomplete Spinal Cord Injury at BeyondThe Chair - Video

Recommendation and review posted by sam

Kim Solez Update on Technology and Future of Medicine Course LMP Rounds 9 25 14
Dr. Kim Solez presents Update on the Technology and Future of Medicine Course: Space, Regenerative Medicine, Large Touch Screens, and Leonard Cohen on September 25, 2014 at LMP Rounds.

By: Kim Solez

View post:
Kim Solez Update on Technology and Future of Medicine Course LMP Rounds 9 25 14 - Video

Recommendation and review posted by sam

The Aspen Institute for Anti-Aging Regenerative Medicine - Age Management Program
The Aspen Institute for Anti-Aging Regenerative Medicine - Age Management Program.

By: Cupio Media

View original post here:
The Aspen Institute for Anti-Aging & Regenerative Medicine - Age Management Program - Video

Recommendation and review posted by sam

Stem Cell Indonesia | Stem Cell Therapy | 0818 09055022
Stem Cell Indonesia Stem Cell Therapy Info: http://www.fullofblessings.jeunesseglobal.com 2A9F978E / +62818 09055022.

By: Stem Cell Indonesia

See the article here:
Stem Cell Indonesia | Stem Cell Therapy | 0818 09055022 - Video

Recommendation and review posted by simmons

Edgar Irastorza was just 31 when his heart stopped beating in October 2008.

A Miami property manager, break-dancer and former high school wrestler, Irastorza had recently gained weight as his wifes third pregnancy progressed. I kind of got pregnant, too, he said.

During a workout one day, he felt short of breath and insisted that friends rush him to the hospital. Minutes later, his pulse flat-lined.

He survived the heart attack, but the scar tissue that resulted cut his hearts pumping ability by a third. He couldnt pick up his children. He couldnt dance. He fell asleep every night wondering if he would wake up in the morning.

Desperation motivated Irastorza to volunteer for a highly unusual medical research trial: getting stem cells injected directly into his heart.

I just trusted my doctors and the science behind it, and said, This is my only chance, he said recently.

Over the last five years, by studying stem cells in lab dishes, test animals and intrepid patients like Irastorza, researchers have brought the vague, grandiose promises of stem cell therapies closer to reality.

Stem cells broke into the public consciousness in the early 1990s, alluring for their potential to help the body beat back diseases of degeneration like Alzheimers, and to grow new parts to treat conditions like spinal cord injuries.

Progress has been slow. The Michael J. Fox Foundation for Parkinsons Research, an early supporter of stem cell research, pulled its financial backing two years ago, saying that it preferred to invest in research that was closer to providing immediate help for Parkinsons disease patients.

But researchers have been slowly learning how to best use stem cells, what types to use and how to deliver them to the body findings that arent singularly transformational, but progressive and pragmatic.

See the article here:
Stem cell therapies making slow but promising progress

Recommendation and review posted by Bethany Smith

Parkinson Stem Cell Treatment In India
India is one of the top destinations when it comes to stem cell therapy due to the fact medical centers here provide Parkinson stem cell treatment at affordable prices and offer best treatment...

By: placidways

See the rest here:
Parkinson Stem Cell Treatment In India - Video

Recommendation and review posted by Bethany Smith

MANILA -- The use of stem cell therapy has become an option in treating different medical conditions.

Stem cells are the body's natural healing cells. They are used by human tissues to repair and regenerate damaged cells. In the right environment, stem cells can change into bone, cartilage, muscle, fat, collagen, neural tissue, blood vessels, and even some organs.

There are two kinds of stem cells: adult or embryonic. Adult stem cells appear to be particularly effective against painful joints, repairing cartilage and ligaments, and even painful conditions along the spine.

Adult stem cells are usually harvested from fat tissues. By using technology, the collagen that binds the fat and the stem cells are broken down, separating a solution rich in the patient's own stem cells, which will then be used for treatment.

Stem cells may be effective in the treatment of macular degeneration, Crohns disease and numerous pulmonary conditions such as chronic obstructive pulmonary disease (COPD), asthma, and fibrosis. Stem cells are also being used for patients suffering from kidney failure and ailments of the bone, cartilage and joints.

However, stem cell therapy is not recommended for patients with active infections or cancer.

In the Philippines, fat-derived stem cell therapy is available through StemCare Institute. At present, the clinic employs an orthopedic team of doctors and surgeons with international qualifications.

StemCare, with the advancement of stem cell technology and the refinement its of clinical protocols through international experts, now offers more accessible treatment options for patients suffering from these degenerative orthopedic conditions.

Kim Atienza and Inno Sotto. Composite Image

Among the personalities who have used stem cell therapy in the country are Inno Sotto, a fashion designer who is suffering from a tear in his right elbow, and Kim Atineza, who is using fat stem cell injections to help strengthen and repair his knee joints after suffering from Guillain-Barre disease.

More here:
How stem cells help cure diseases

Recommendation and review posted by Bethany Smith

Pfizer Inc. (PFE)s Xalkori for advanced lung cancer shrunk tumors in those with a rare genetic mutation, according to a study that may provide the first targeted treatment for these patients.

Xalkori reduced the size of tumors in 36 of 50 patients in the study while halting tumor growth in another nine, according to company-funded research released today at the European Society for Medical Oncology meeting in Madrid and online in the New England Journal of Medicine.

About 15,000 people, or 1 percent of the estimated 1.5 million annual new cases of non-small-cell lung cancer, have an abnormality to the ROS1 gene, according to New York-based Pfizer. Todays findings also showed that Xalkori was effective for about 18 months in patients, longer than the average eight to 12 months seen for some other targeted treatments, said Alice Shaw, a lead study author.

Were seeing much longer durations of remissions, Shaw, an associate professor of medicine at Harvard Medical School and Massachusetts General Hospital in Boston, said in a telephone interview. This points to being a very good target in lung cancer and this drug being a very effective targeted therapy for these patients.

Xalkori helps shut off the ROS1 gene that is causing cancer tumors to grow, she said. It was approved in 2011 to treat non-small-cell lung cancers in patients with mutations to the ALK gene, which has structural similarities to the ROS1 gene. The National Comprehensive Cancer Network, an alliance of 25 cancer centers, already recommends that doctors use Xalkori in patients who have this gene defect.

Pfizer continues to support clinical research of Xalkori in patients with ROS1 rearrangements to better understand the compounds activity in this population, Sally Beatty, a company spokeswoman, said in an e-mail.

The cancer drug generated $282 million in 2013 sales, according to data compiled by Bloomberg. The drug may produce revenue of more than $812 million in 2017, according to the average of five analysts estimates.

Patients with a mutation to the ROS1 gene are often younger and usually arent smokers, Shaw said.

Todays study is an expansion of the original Phase 1 clinical trial of Xalkori in patients with the ALK gene mutation. Researchers enrolled 50 patients who were ROS1 positive starting in late 2010 through August 2013. Those in the study received Xalkori two times daily.

By the end of the trial, half of the patients were still getting Xalkori and had no signs of their tumors growing, the authors said.

Original post:
Pfizers Lung Cancer Drug Helps Patients With Gene Defect

Recommendation and review posted by Bethany Smith

Genetic engineering in plants
This plant genetic engineering lecture explains different process and techniques used in plant biotechnology in overview session. For more information, log o...

By: Suman Bhattacharjee

Read the original here:
Genetic engineering in plants - Video

Recommendation and review posted by Bethany Smith

The Sims 3 - Perfect Genetics Challenge Ep.50 Birthday Lightning Strike
Come join me on my latest journey into the complex world of sims 3 genetics, as I try to get perfect foals and perfect children. Will I succeed in getting pe...

By: GamerGirlsNetwork

Excerpt from:
The Sims 3 - Perfect Genetics Challenge Ep.50 Birthday Lightning Strike - Video

Recommendation and review posted by Bethany Smith

Anorexia Nervosa Genetics Initiative
The Anorexia Nervosa Genetics Initiative (ANGI) is a global effort to identify genes that contribute to eating disorders. The goal of the study is to transfo...

By: QIMR Berghofer Medical Research Institute

See more here:
Anorexia Nervosa Genetics Initiative - Video

Recommendation and review posted by Bethany Smith